Find therapies in clinical trials near you – page 29

Efficacy and Safety of Pegcetacoplan in Adults and Adolescents with Focal Segmental Glomerulosclerosis: Phase 2/3 Open‑Label and Randomized Placebo‑Controlled Study

Efficacy and Safety of Pegcetacoplan in Adults and Adolescents with Focal Segmental Glomerulosclerosis: Phase 2/3 Open‑Label and Randomized Placebo‑Controlled Study

Study of blinatumomab plus drug combination in children and adolescents with acute lymphoblastic leukemia

Study of blinatumomab plus drug combination in children and adolescents with acute lymphoblastic leukemia

Dalbavancin versus standard drug combination for treatment of infective endocarditis caused by Gram‑positive cocci in adult patients

Dalbavancin versus standard drug combination for treatment of infective endocarditis caused by Gram‑positive cocci in adult patients

Efficacy of asciminib in chronic phase chronic myeloid leukemia patients with T315I mutation

Efficacy of asciminib in chronic phase chronic myeloid leukemia patients with T315I mutation

Study of CC-97540 (CD19‑Targeted NEX‑T CAR T) versus drug combination in adults with active systemic sclerosis

Study of CC-97540 (CD19‑Targeted NEX‑T CAR T) versus drug combination in adults with active systemic sclerosis

Efficacy of efgartigimod alfa as first‑line add‑on to IV methylprednisolone for moderate‑to‑severe attacks in patients with demyelinating diseases

Shortening treatment duration in adults with uncomplicated candidemia: caspofungin acetate versus saline and sodium lactate placebo

Shortening treatment duration in adults with uncomplicated candidemia: caspofungin acetate versus saline and sodium lactate placebo

A study to evaluate the effectiveness and safety of vamifeport in adults with hereditary hemochromatosis

A study to evaluate the effectiveness and safety of vamifeport in adults with hereditary hemochromatosis

A study to evaluate the safety and effectiveness of subcutaneous blinatumomab in adults and adolescents with relapsed, refractory, or minimal residual disease positive B-cell precursor acute lymphoblastic leukemia.

A study to evaluate the safety and effectiveness of subcutaneous blinatumomab in adults and adolescents with relapsed, refractory, or minimal residual disease positive B-cell precursor acute lymphoblastic leukemia.

A study to evaluate the effectiveness and safety of admilparant in patients with progressive pulmonary fibrosis

A study to evaluate the effectiveness and safety of admilparant in patients with progressive pulmonary fibrosis

A study to evaluate the effectiveness and safety of admilparant in patients with idiopathic pulmonary fibrosis

A study to evaluate the effectiveness and safety of admilparant in patients with idiopathic pulmonary fibrosis

Phase 3 Randomized Study of Niraparib Tosilate Monohydrate vs. Temozolomide in Newly Diagnosed MGMT Unmethylated Glioblastoma

Phase 3 Randomized Study of Niraparib Tosilate Monohydrate vs. Temozolomide in Newly Diagnosed MGMT Unmethylated Glioblastoma